Cancer is one of the leading causes of death worldwide. In 2020, around 10 million people lost their lives to cancer, and the number is expected to rise to 29.5 million by 2040. Over the years, many conventional treatment approaches have been developed for cancer like chemotherapy, bone marrow transplant, radiation therapy, surgery, and more
The increasing life expectancy of humans has led to a rising number of patients living with chronic disorders, which may ultimately require organ transplantation for the treatment of their condition and prevent end-stage organ failure. Although clinical transplantation is an effective solution to save lives, the imbalance between organ supply and demand for human organs
Amidst the macroeconomic, structural, and microeconomic shifts caused by the COVID-19 pandemic, the Indian pharmaceutical industry responded with agility, exceeding the expectations of governments and markets across geographies. The overall growth of the Indian pharmaceutical industry can be largely attributed to the industry’s leadership in supplying generic formulations to the market, supplying over 40% of
According to a report published by Deloitte, the Internet of Medical Things (IoMT) is anticipated to reach USD158.1 billion in 2022. The internet of medical things is a connected infrastructure of inter-networked medical devices and healthcare information technology applications, which allows the collection, analysis, and transmission of data. IoMT and its relationship with MedTech enable healthcare organizations
Since the onset of the COVID-19 pandemic in 2020, researchers have been continuously striving towards developing effective therapies to contain the virus and minimize its implications on the affected individuals. While wearing masks, social-distancing, sanitization, and vaccination remained the leading options for preventing the transmission of infections, the upsurge in the latest coronavirus mutation, Omicron
The Indian Pharmaceutical industry has evolved incredibly in the past five decades, becoming the sunrise sector of the country. According to India’s Ministry of External Affairs, the Indian Pharmaceutical sector is poised to grow to USD100 billion by 2025 with its radical innovation and ability to provide medicines and medical support to various nations across the globe. Even during
The coronavirus pandemic in 2020 has dramatically altered the way healthcare is practiced across the world. Even 2021 presented its own set of challenges for healthcare providers, such as divergent views on vaccines, powerful COVID-19 variants, lack of certain medical equipment. Amidst all the chaos, the healthtech industry managed to overcome all the difficulties by
In the United States, every two seconds someone requires blood either for routine medical procedures or emergency situations. For patients suffering from acute and chronic medical conditions, blood transfusion is an indispensable component of healthcare capable of improving their life expectancy and overall quality of life. Approx. 29000 units of red blood cells, 5000 units of platelets, and 6500 units of plasma are
The growing geriatric population and increasing prevalence of degenerative and chronic diseases have created a need for modern healthcare solutions that limit organ dysfunction and tissue degeneration. Regenerative medicine therapies focused on rejuvenation, regeneration, and replacement are changing how we think about medicine. Advances in cell therapies continue to be at the forefront of healthcare innovation, transforming
There has been a crazy new trend of ginormous global companies dismantling into multiple entities as diversification isn’t a rage in the corporate world. Companies like Johnson & Johnson, GE, Pfizer, Merck, GlaxoSmithKline have recently announced their corporate divorces, but the splits are not confined to the healthcare sector. Many tech giants, global retail brands,
